
Loading, please wait...

Loading, please wait...

Clinical teams are continuously refining liver transplantation outcomes through institutional expertise and technological adoption. A recent study at Changwon Hanmaeum Hospital in South Korea analyzed 56 cases from January 2023 to July 2025. Furthermore, researchers categorized the procedures into 29 living donor (LDLT) and 27 deceased donor (DDLT) types. Specifically, the team documented primary diagnoses, MELD scores, and surgical details to evaluate program progress. Moreover, patients with alcoholic or hepatitis B-related cirrhosis comprised the majority of the cohort. Consequently, the data revealed that DDLT recipients generally exhibited higher MELD scores than LDLT recipients. Therefore, surgeons must navigate higher medical urgency in deceased donor cases while maintaining graft safety.
The hospital observed significant surgical improvements over the two-and-a-half-year period. Specifically, the average recipient operative time decreased from 429 minutes to 360 minutes. Similarly, the adoption of laparoscopic donor hepatectomy reflects a growing shift toward minimally invasive surgery. However, eight donors required conversion to open surgery during the study period. Additionally, survival to discharge reached 90.5% in 2025, marking a significant institutional milestone compared to earlier rates. Thus, cumulative surgical experience and optimized management are key drivers of success. Nevertheless, infectious complications like bacterial pneumonia remain a challenge. Consequently, multidisciplinary collaboration is essential for optimizing liver transplantation outcomes and long-term recovery.
The research identified alcoholic cirrhosis (39.3%) and hepatitis B-related cirrhosis (26.8%) as the primary indications for transplantation in this cohort. These conditions represent the leading causes of end-stage liver disease in the analyzed population.
The average recipient operative time decreased significantly from 429 minutes in the early phase to 360 minutes in 2025. This improvement reflects enhanced surgical proficiency and more streamlined perioperative processes at the institution.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Budiman D et al. Evolving trends and outcomes in living and deceased donor liver transplantation: institutional experience from Changwon Hanmaeum Hospital (2023-2025). Clin Transplant Res. 2026 May 22. doi: 10.4285/ctr.25.0070. PMID: 42168769.
Kim J et al. Superior survival outcomes of living donor liver transplantation in Korea: A large-scale national comparison. Asian Transplant Week 2025 proceedings.
Lee SG et al. Global dissemination of minimally invasive donor hepatectomy and surgical barriers. Transplantation. 2025 Nov 1;109(11):1754-1764.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A retrospective study highlights significant improvements in liver transplantation outcomes, survival rates, and surgical efficiency from 2023 to 2025....
5 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday